Communicating Complex Science in an Era of Shrinking Attention

A clinical trial can take years to complete. A scientific discovery can take decades to build. A breakthrough therapy can transform the future of healthcare. Yet doctors often get only a few seconds to explain why it matters. This contradiction has shaped the journey of medical communications, standing between two worlds: science, where every decimal point matters, and audiences, where attention is fleeting and clarity is everything.

The challenge in MedComms begins with language. Early careers in the field are built on clinical outcomes, evidence, mechanisms, and data. Over time, the role evolves into something harder to define: helping science find its human voice. The question is no longer whether the science is important. It is whether we can make people care enough to listen. Somewhere between a 30-second reel and an endless scroll, health information is battling not just misinformation but indifference.

From scientific accuracy to human understanding

In the pharmaceutical industry, complexity in communications is expected. The audience has the expertise to interpret it. Healthcare professionals are trained to weigh evidence, read data, and apply findings to practice. The moment that audience expands to include patients, caregivers, policymakers, and communities navigating unfamiliar medical terms, the rules change entirely.

Information alone does not create understanding. A scientific breakthrough may be remarkable. A treatment option may be life-changing. But if people cannot understand why it matters to them, the message has not truly connected. More time is often spent debating a headline, a patient quote, or an opening paragraph than discussing the science itself, because those first few lines determine whether someone stays engaged at all.

Read the full article on SPAG/FINN Partners